A new study shows a strong association between androgen-deprivation therapy for advanced prostate cancer, and the development of Alzheimer's disease. This is a retrospective data-based study, so no change in treatment using ADT is indicated now. Further, prospective studies are needed. Continue reading
The post Hormonal Treatment of Prostate Cancer Linked to Alzheimer’s Disease appeared first on American Council on Science and Health.